Headlands Technologies LLC Ascendis Pharma A/S Transaction History
Headlands Technologies LLC
- $920 Million
- Q2 2024
A detailed history of Headlands Technologies LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Headlands Technologies LLC holds 6,338 shares of ASND stock, worth $802,073. This represents 0.09% of its overall portfolio holdings.
Number of Shares
6,338Holding current value
$802,073% of portfolio
0.09%Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
226Shares Held
56.6MCall Options Held
138KPut Options Held
249K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.28 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$628 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$544 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$531 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$496 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.06B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...